创新药板块持续领涨医药主题基金强势回归市场C位

环球网2025-08-03

【环球网财经综合报道】今年以来，资本市场最炙手可热的投资主线之一——创新药板块，在政策、技术、资金三重共振下持续爆发，不仅带动医药行业整体估值修复，更推动医药主题基金成为市场“吸金利器”。数据显示，7月以来多只医药主题基金单月涨幅超30%，年内业绩榜单前十中九席被医药产品占据，资金对创新药赛道的追捧热度创下近三年新高。自年初以来，创新药板块便以“黑马”姿态领跑市场。从A股的恒瑞医药、百济神州，到...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2556821408?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-03 09:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2556821408","market":"us","top_or_hot":-1,"title":"创新药板块持续领涨 医药主题基金强势回归市场C位","media":"环球网","content":"<div>\n<p>【环球网财经综合报道】今年以来，资本市场最炙手可热的投资主线之一——创新药板块，在政策、技术、资金三重共振下持续爆发，不仅带动医药行业整体估值修复，更推动医药主题基金成为市场“吸金利器”。数据显示，7月以来多只医药主题基金单月涨幅超30%，年内业绩榜单前十中九席被医药产品占据，资金对创新药赛道的追捧热度创下近三年新高。自年初以来，创新药板块便以“黑马”姿态领跑市场。从A股的恒瑞医药、百济神州，到...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803094058a6cfdfe4&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>创新药板块持续领涨 医药主题基金强势回归市场C位</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n创新药板块持续领涨 医药主题基金强势回归市场C位\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-03 09:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803094058a6cfdfe4&s=b><strong>环球网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【环球网财经综合报道】今年以来，资本市场最炙手可热的投资主线之一——创新药板块，在政策、技术、资金三重共振下持续爆发，不仅带动医药行业整体估值修复，更推动医药主题基金成为市场“吸金利器”。数据显示，7月以来多只医药主题基金单月涨幅超30%，年内业绩榜单前十中九席被医药产品占据，资金对创新药赛道的追捧热度创下近三年新高。自年初以来，创新药板块便以“黑马”姿态领跑市场。从A股的恒瑞医药、百济神州，到...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803094058a6cfdfe4&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4526","symbol_name":"热门中概股","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803094058a6cfdfe4&s=b","article_id":"2556821408","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250803094058a6cfdfe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2556821408","pubTimestamp":1754185206,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"自年初以来，创新药板块便以“黑马”姿态领跑市场。医药基金“王者归来”，单月最高涨34%。其中，永赢医药健康A以34.2%的单月涨幅领跑，华富健康文娱A、中银创新医疗A等7只基金涨幅超30%，形成明显的“赚钱效应”。年内业绩排名前十的主动权益类基金中，中银创新医疗A、融通健康产业A等9只产品均聚焦医药领域，与去年同期的“无人问津”形成鲜明对比。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4526":"热门中概股","BK4139":"生物科技","ONC":"百济神州","BK4585":"ETF&股票定投概念"},"translate_title":"The innovative drug sector continues to lead the rise, and pharmaceutical-themed funds return strongly to the C position in the market","themeId":"fd6a6c70759e8ef3649b21dc64b4506e","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONC":0.9},"content_text":"【环球网财经综合报道】今年以来，资本市场最炙手可热的投资主线之一——创新药板块，在政策、技术、资金三重共振下持续爆发，不仅带动医药行业整体估值修复，更推动医药主题基金成为市场“吸金利器”。数据显示，7月以来多只医药主题基金单月涨幅超30%，年内业绩榜单前十中九席被医药产品占据，资金对创新药赛道的追捧热度创下近三年新高。自年初以来，创新药板块便以“黑马”姿态领跑市场。从A股的恒瑞医药、百济神州，到港股的信达生物、康方生物，相关标的股价屡创新高，带动医药生物指数年内累计涨幅超过25%，显著跑赢大盘。7月，随着全球医药巨头并购潮涌动、国产创新药海外授权频传捷报，板块情绪进一步升温，单月指数涨幅突破12%，成为资金加仓的核心方向。“创新药已从‘主题投资’转向‘产业趋势投资’。”某公募基金医药行业研究员表示，政策端，医保谈判简化、审评审批加速等改革持续落地；技术端，ADC（抗体偶联药物）、双抗、细胞治疗等前沿领域进入成果收获期；资本端，美联储加息周期接近尾声，全球生物医药投融资环境回暖，共同构成了本轮行情的底层逻辑。医药基金“王者归来”，单月最高涨34%。板块的强劲表现直接反映在基金净值上。Wind数据显示，截至7月31日，全市场200余只医药主题基金（AC份额合并计算）中，超过80%年内实现正收益。其中，永赢医药健康A以34.2%的单月涨幅领跑，华富健康文娱A、中银创新医疗A等7只基金涨幅超30%，形成明显的“赚钱效应”。拉长时间维度看，医药基金的复苏势头更为显著。年内业绩排名前十的主动权益类基金中，中银创新医疗A、融通健康产业A等9只产品均聚焦医药领域，与去年同期的“无人问津”形成鲜明对比。某头部基金公司市场部负责人透露：“近期渠道调研显示，投资者对医药基金的关注度提升至2021年以来的最高水平，新发基金中医疗健康主题占比超过40%。”驱动医药基金回暖的，除了短期业绩催化，更有长期逻辑的支撑。公募基金二季报显示，医药板块重获资金青睐，持仓比例环比提升1.2个百分点至12.5%，结束连续6个季度的下滑趋势。与此同时，北向资金7月单月净买入医药生物行业超80亿元，位居所有板块首位。“当前医药行业估值仍处于历史中位数以下，但产业创新周期已不可逆。”某百亿级基金经理强调，随着国内药企从“跟随创新”向“源头创新”跃迁，叠加国际化进程加速，未来3-5年将涌现一批具备全球竞争力的企业，为投资者创造超额收益。市场分析人士指出，尽管短期交易拥挤度有所上升，但医药作为典型的“长坡厚雪”赛道，其战略配置价值未变。建议投资者关注创新药产业链、高端医疗器械、消费医疗等细分领域，通过定投或分批建仓的方式分享行业成长红利。从“至暗时刻”到“聚光灯下”，医药行业的反转行情印证了“创新驱动增长”的长期逻辑。（水手）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2556821408","isCrawlerRequest":true}

创新药板块持续领涨 医药主题基金强势回归市场C位

精彩评论

创新药板块持续领涨医药主题基金强势回归市场C位